pta20240613025
Release according to article 40 para. 1 WpHG

Biofrontera AG: Release according to Article 40, Section 1 of the WpHG

Leverkusen, Germany (pta025/13.06.2024/16:20 UTC+2) - Release of Voting Rights Announcement

Voting Rights Announcement

1. Details of issuer

Name: Biofrontera AG
Legal Entity Identifier (LEI): 391200D6GFSVFGFQTL13
Street: Hemmelrather Weg 201
Postal code: 51377
City: Leverkusen, Germany

2. Reason for notification
Acquisition / disposal of shares with voting rights
Change of Total Voting Rights

3. Details of person subject to the notification obligation
Natural person (first name, surname): Wilhelm K. T. Zours
Date of birth: 28.07.1961

4. Names of shareholders holding directly 3% or more voting rights, if different from 3.
DELPHI Unternehmensberatung Aktiengesellschaft
Deutsche Balaton Aktiengesellschaft
SPARTA AG
Deutsche Balaton Biotech AG

5. Date on which threshold was crossed or reached
12.06.2024

6. Total positions

  % of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) Total of both in % (7.a. + 7.b.) Total number of voting rights pursuant to Sec. 41 WpHG
New 61.20 0.00 61.20 6,076,862
Previous notification (if applicable) 30.01 2.91 32.92

7. Details on total positions

a. Voting rights attached to shares (Sec.s 33, 34 WpHG)

ISIN Absolute direct (Sec. 33 WpHG) Absolute indirect (Sec. 34 WpHG) In % direct (Sec. 33 WpHG) In % indirect (Sec. 34 WpHG)
DE000A4BGGM7 0 781,784 0.00 12.86
DE000A409625 0 2,937,462 0.00 48.34
Total:   3,719,246   61.20

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG

type of instrument Maturity / Expiration Exercise or conversion period Voting Rights Absolute Voting Rights in %
0 0.00
    Total: 0 0.00

b.2. Instruments according to Sec. 38 (1) no. 2 WpHG

type of instrument Maturity / Expiration Exercise or conversion period Cash or physical transaction Voting Rights Absolute Voting Rights in %
0 0.00
      Total: 0 0.00

8. Information in relation to the person subject to the notification obligation

Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity

Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more)
- Wilhelm K. T. Zours
- DELPHI Unternehmensberatung Aktiengesellschaft 61.20 61.20
- VV Beteiligungen Aktiengesellschaft
- Deutsche Balaton Aktiengesellschaft 61.20 61.20
- Heidelberger Beteiligungsholding AG 61.20 61.20
-
- Wilhelm K. T. Zours
- DELPHI Unternehmensberatung Aktiengesellschaft 61.20 61.20
- VV Beteiligungen Aktiengesellschaft
- Deutsche Balaton Aktiengesellschaft 61.20 61.20
- SPARTA AG 61.20 61.20
-
- Wilhelm K. T. Zours
- DELPHI Unternehmensberatung Aktiengesellschaft 61.20 61.20
- VV Beteiligungen Aktiengesellschaft
- Deutsche Balaton Aktiengesellschaft 61.20 61.20
- Deutsche Balaton Biotech AG 61.20 61.20

9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)

Date of general meeting: N/A

Holding total positions (6.) after general meeting:

Proportion of voting rights Proportion of instruments Total of both
% % %

10. Other useful information

DELPHI Unternehmensberatung AG, Deutsche Balaton AG, SPARTA AG, Deutsche Balaton Biotech AG and Heidelberger Beteiligungsholding AG are parties to a voting trust agreement.

Date
13.06.2024

(end)

Emitter: Biofrontera AG
Hemmelrather Weg 201
51377 Leverkusen
Germany
Contact Person: Investor Relations
Phone: +49 (0) 214 87 63 20
E-Mail: ir@biofrontera.com
Website: www.biofrontera.com
ISIN(s): DE000A4BGGM7 (Share)
Stock Exchange(s): Regulated Market in Dusseldorf, Frankfurt; Free Market in Berlin, Munich, Stuttgart, Tradegate
|